Ordinary Rebalance | Solactive Genomics Index | Effective Date 13th November 2023
In the ordinary rebalance, the following composition will be implemented effective open 13.11.2023:
| 10X GENOMICS INC |
| 2SEVENTY BIO INC-W/I |
| AGILENT TECHNOLOGIES INC |
| ALLOGENE THERAPEUTICS INC |
| ALNYLAM PHARMACEUTICALS INC |
| ARROWHEAD PHARMACEUTICALS INC |
| BEAM THERAPEUTICS INC |
| BIO-TECHNE CORP |
| BIOMARIN PHARMACEUTICAL INC |
| BIONANO GENOMICS INC |
| BIONTECH SE |
| BLUEBIRD BIO INC |
| CAREDX INC |
| CARIBOU BIOSCIENCES INC |
| CRISPR THERAPEUTICS AG |
| EDITAS MEDICINE INC |
| FULGENT GENETICS INC |
| GENSCRIPT BIOTECH CORP |
| GILEAD SCIENCES INC |
| ILLUMINA INC |
| INTELLIA THERAPEUTICS INC |
| INVITAE CORP |
| MODERNA INC |
| MYRIAD GENETICS INC |
| NANOSTRING TECHNOLOGIES INC |
| NATERA INC |
| PACIFIC BIOSCIENCES OF CALIFORNIA INC |
| POSEIDA THERAPEUTICS INC |
| QIAGEN NV |
| REGENXBIO INC |
| ROCKET PHARMACEUTICALS INC |
| SANGAMO THERAPEUTICS INC |
| SAREPTA THERAPEUTICS INC |
| STOKE THERAPEUTICS INC |
| TAKARA BIO INC |
| ULTRAGENYX PHARMACEUTICAL INC |
| UNIQURE B.V. |
| VERACYTE INC |
| VERTEX PHARMACEUTICALS INC |
| VERVE THERAPEUTICS INC |